Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Oct;36(10):2328–2330. doi: 10.1128/aac.36.10.2328

Low-dose trimethoprim-sulfamethoxazole alone and in association with zidovudine for prevention and treatment of murine Pneumocystis carinii pneumonia.

M Brun-Pascaud 1, P M Girard 1, J J Pocidalo 1
PMCID: PMC245497  PMID: 1444313

Abstract

Low-dose trimethoprim-sulfamethoxazole (TMP-SMX) alone was found to be as effective as low-dose TMP-SMX plus zidovudine and standard-dose TMP-SMX alone in preventing and treating Pneumocystis carinii pneumonia (PCP) in an immunosuppressed-rat model. Zidovudine alone had no preventive or curative effect on PCP. We conclude that the initially reported reduced incidence of PCP in human immunodeficiency virus-infected patients treated with zidovudine alone is not due to anti-P. carinii activity of zidovudine. Furthermore, the clinical efficacy of low-dose TMP-SMX for the prevention and treatment of PCP should be further investigated.

Full text

PDF
2328

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fischl M. A., Dickinson G. M., La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA. 1988 Feb 26;259(8):1185–1189. doi: 10.1001/jama.259.8.1185. [DOI] [PubMed] [Google Scholar]
  2. Fischl M. A., Parker C. B., Pettinelli C., Wulfsohn M., Hirsch M. S., Collier A. C., Antoniskis D., Ho M., Richman D. D., Fuchs E. A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med. 1990 Oct 11;323(15):1009–1014. doi: 10.1056/NEJM199010113231501. [DOI] [PubMed] [Google Scholar]
  3. Fischl M. A., Richman D. D., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Schooley R. T. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):185–191. doi: 10.1056/NEJM198707233170401. [DOI] [PubMed] [Google Scholar]
  4. Frenkel J. K., Good J. T., Shultz J. A. Latent Pneumocystis infection of rats, relapse, and chemotherapy. Lab Invest. 1966 Oct;15(10):1559–1577. [PubMed] [Google Scholar]
  5. Girard P. M., Brun-Pascaud M., Farinotti R., Tamisier L., Kernbaum S. Pentamidine aerosol in prophylaxis and treatment of murine Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 1987 Jul;31(7):978–981. doi: 10.1128/aac.31.7.978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hughes W. T. Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 1988 May;32(5):623–625. doi: 10.1128/aac.32.5.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hughes W. T., Killmar J. T. Synergistic anti-Pneumocystis carinii effects of erythromycin and sulfisoxazole. J Acquir Immune Defic Syndr. 1991;4(5):532–537. [PubMed] [Google Scholar]
  8. Hughes W. T., McNabb P. C., Makres T. D., Feldman S. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother. 1974 Mar;5(3):289–293. doi: 10.1128/aac.5.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hughes W. T., Rivera G. K., Schell M. J., Thornton D., Lott L. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med. 1987 Jun 25;316(26):1627–1632. doi: 10.1056/NEJM198706253162604. [DOI] [PubMed] [Google Scholar]
  10. Hughes W. T., Smith B. L. Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother. 1984 Oct;26(4):436–440. doi: 10.1128/aac.26.4.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Keith B. R., White G., Wilson H. R. In vivo efficacy of zidovudine (3'-azido-3'-deoxythymidine) in experimental gram-negative-bacterial infections. Antimicrob Agents Chemother. 1989 Apr;33(4):479–483. doi: 10.1128/aac.33.4.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Queener S. F., Bartlett M. S., Richardson J. D., Durkin M. M., Jay M. A., Smith J. W. Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother. 1988 Jun;32(6):807–813. doi: 10.1128/aac.32.6.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ruskin J., LaRiviere M. Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease. Lancet. 1991 Feb 23;337(8739):468–471. doi: 10.1016/0140-6736(91)93402-u. [DOI] [PubMed] [Google Scholar]
  14. Salmon D., Detruchis P., Leport C., Bouvet E., Karam D., Meyohas M. C., Coulaud J. P., Vildé J. L. Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS. J Infect Dis. 1991 Feb;163(2):415–416. doi: 10.1093/infdis/163.2.415. [DOI] [PubMed] [Google Scholar]
  15. Sinet M., Desforges B., Launay O., Colin J. N., Pocidalo J. J. Factors influencing zidovudine efficacy when administered at early stages of Friend virus infection in mice. Antiviral Res. 1991 Sep;16(2):163–171. doi: 10.1016/0166-3542(91)90022-j. [DOI] [PubMed] [Google Scholar]
  16. Stein D. S., Stevens R. C., Terry D., Laizure S. C., Palte S., Lancaster D. J., Weems J. J., Williams C. L. Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 1991 Sep;35(9):1705–1709. doi: 10.1128/aac.35.9.1705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Walzer P. D., Rutledge M. E., Yoneda K., Stahr B. J. Pneumocystis carinii: new separation method from lung tissue. Exp Parasitol. 1979 Jun;47(3):356–368. doi: 10.1016/0014-4894(79)90088-2. [DOI] [PubMed] [Google Scholar]
  18. Wormser G. P., Horowitz H. W., Duncanson F. P., Forseter G., Javaly K., Alampur S. K., Gilroy S. A., Lenox T., Rappaport A., Nadelman R. B. Low-dose intermittent trimethoprim-sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. Arch Intern Med. 1991 Apr;151(4):688–692. [PubMed] [Google Scholar]
  19. Yoshida Y., Ikai T. Pneumocystis carinii pneumonia: epidemiology in Japan, and cyst concentration method. Zentralbl Bakteriol Orig A. 1979 Jul;244(2-3):405–410. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES